𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Urinary immunoglobulin A in the diagnosis of bladder cancer

✍ Scribed by V. Betkerur; G. Baumgartner; K. Talluri; R. Sharifi; S. Nagubadi; P. Guinan

Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
160 KB
Volume
16
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Delays in diagnosis and bladder cancer m
Delays in diagnosis and bladder cancer mortality
✍ Brent K. Hollenbeck; Rodney L. Dunn; Zaojun Ye; John M. Hollingsworth; Ted A. Sk πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 162 KB
Analysis of the expression of biomarkers
Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray
✍ Loleta D. Harris; Jorge De La Cerda; Tomasz Tuziak; Daniel Rosen; Lianchun Xiao; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 432 KB

## Abstract Dysregulation of Akt, PTEN, Drg‐1, Cx‐26, and L‐plastin expression appear to be important in the progression of various cancers. Their expression in bladder cancer has not been well characterized. To assess the expression of these genes and their relationship to the outcome of bladder c

HER-2 and TOP2A coamplification in urina
HER-2 and TOP2A coamplification in urinary bladder cancer
✍ Ronald Simon; Ramin Atefy; Urs Wagner; Thomas Forster; AndrΓ© Fijan; James Bruder πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 357 KB

## Abstract __HER‐2/NEU__ is one of the most frequently amplified oncogenes and a potential therapeutic target in bladder cancer. In breast cancer, the adjacent __TOP2A__ gene, the molecular target for several anticancer drugs, is frequently coamplified together with __HER‐2__. To study the amplifi